Qianwei Ye

955 total citations
15 papers, 511 citations indexed

About

Qianwei Ye is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Qianwei Ye has authored 15 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Qianwei Ye's work include RNA modifications and cancer (3 papers), Autophagy in Disease and Therapy (3 papers) and Ubiquitin and proteasome pathways (3 papers). Qianwei Ye is often cited by papers focused on RNA modifications and cancer (3 papers), Autophagy in Disease and Therapy (3 papers) and Ubiquitin and proteasome pathways (3 papers). Qianwei Ye collaborates with scholars based in China, Madagascar and United States. Qianwei Ye's co-authors include Shusen Zheng, Sunbin Ling, Xiao Xu, Haiyang Xie, Shengjun Xu, Jufeng Guo, Shufang Hu, Qifan Zhan, Qiaonan Shan and Guangjiang Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Cancer and Advanced Science.

In The Last Decade

Qianwei Ye

15 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qianwei Ye China	11	253	219	126	119	95	15	511
Yantao Chai China	11	276 1.1×	207 0.9×	160 1.3×	108 0.9×	48 0.5×	19	551
Yuchao He China	12	393 1.6×	303 1.4×	112 0.9×	40 0.3×	121 1.3×	25	593
Hanzhang Zhu China	11	180 0.7×	115 0.5×	103 0.8×	53 0.4×	78 0.8×	18	377
Changku Jia China	10	238 0.9×	91 0.4×	115 0.9×	60 0.5×	55 0.6×	22	427
Yuqiang Shan China	9	178 0.7×	112 0.5×	81 0.6×	48 0.4×	82 0.9×	30	359
Allen Zhang United States	10	397 1.6×	141 0.6×	133 1.1×	34 0.3×	76 0.8×	16	565
Nguyen H. Tran United States	11	147 0.6×	122 0.6×	249 2.0×	97 0.8×	88 0.9×	59	470
Eunsun Jung South Korea	13	228 0.9×	102 0.5×	110 0.9×	42 0.4×	45 0.5×	40	504
Ruixiu Zhang China	10	272 1.1×	138 0.6×	202 1.6×	59 0.5×	24 0.3×	18	492
Runzhou Zhuang China	12	200 0.8×	100 0.5×	55 0.4×	71 0.6×	40 0.4×	21	393

Countries citing papers authored by Qianwei Ye

Since Specialization

Citations

This map shows the geographic impact of Qianwei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianwei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianwei Ye more than expected).

Fields of papers citing papers by Qianwei Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qianwei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianwei Ye. The network helps show where Qianwei Ye may publish in the future.

Co-authorship network of co-authors of Qianwei Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Qianwei Ye. A scholar is included among the top collaborators of Qianwei Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qianwei Ye. Qianwei Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Tao, Rui, Jiaping Wu, Yi Pan, et al.. (2025). A Novel tRF, HCETSR, Derived From tRNA‐Glu/TTC, Inhibits HCC Malignancy by Regulating the SPBTN1‐catenin Complex Axis. Advanced Science. 12(13). e2415229–e2415229. 2 indexed citations

Guo, Jufeng, et al.. (2024). Mitophagy: insights into its signaling molecules, biological functions, and therapeutic potential in breast cancer. Cell Death Discovery. 10(1). 457–457. 15 indexed citations

Chen, Cong, Qianwei Ye, Jufeng Guo, et al.. (2024). Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: insights into apoptosis, autophagy, ferroptosis, and pyroptosis. Cell Death Discovery. 10(1). 30 indexed citations

Ye, Qianwei, Linbo Wang, Jichun Zhou, et al.. (2023). Targeting pyroptosis in breast cancer: biological functions and therapeutic potentials on It. Cell Death Discovery. 9(1). 75–75. 20 indexed citations

Ye, Qianwei, Wei Zhou, Shengjun Xu, et al.. (2023). Ubiquitin‐specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma. SHILAP Revista de lepidopterología. 4(6). e439–e439. 7 indexed citations

Tan, Zhen, Jie Deng, Qianwei Ye, Zuo‐Feng Zhang, & Tianyou Luo. (2023). Current Developments of Pyrrolo[2,3-d]pyrimidines with Anticancer Potential (A Review). Russian Journal of General Chemistry. 93(10). 2645–2662. 2 indexed citations

Xu, Shengjun, Sunbin Ling, Qiaonan Shan, et al.. (2021). Hepatocellular Carcinoma: Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy (Adv. Sci. 5/2021). Advanced Science. 8(5). 1 indexed citations

Ye, Qianwei, Sunbin Ling, Guangjiang Jiang, et al.. (2021). Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria. European Journal of Surgical Oncology. 47(10). 2533–2542. 11 indexed citations

Ding, Ning, Shengjun Xu, Sheng Zheng, et al.. (2021). “Sweet tooth”-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy. Journal of Materials Chemistry B. 9(12). 2816–2830. 17 indexed citations

10.

Xu, Shengjun, Sunbin Ling, Qiaonan Shan, et al.. (2021). Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy. Advanced Science. 8(5). 2003042–2003042. 49 indexed citations

11.

Zhan, Qifan, Sunbin Ling, Yinan Deng, et al.. (2020). Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China. Hepatobiliary & pancreatic diseases international. 19(4). 349–357. 18 indexed citations

12.

Ling, Sunbin, Tingting Feng, Qifan Zhan, et al.. (2020). Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria. Annals of Translational Medicine. 8(4). 80–80. 11 indexed citations

13.

Ye, Qianwei, et al.. (2019). Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Molecular Cancer. 18(1). 114–114. 287 indexed citations

14.

Zhang, Xuanyu, Runzhou Zhuang, Qianwei Ye, et al.. (2019). High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma. Journal of Cancer. 10(6). 1434–1443. 12 indexed citations

15.

Liu, Zhikun, Qianwei Ye, Lingjiao Wu, et al.. (2018). Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma. Molecular Carcinogenesis. 57(11). 1435–1444. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact